Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. products
  3. early prostate cancer
Show results for
Products

Companies

News

Refine by

Early Prostate Cancer Equipment & Supplies

4 equipment items found

MicroPort Toumai - Endoscopic Surgery Robot

MicroPort Toumai - Endoscopic Surgery Robot

Manufactured by:MicroPort Scientific Corporation   based inShanghai, CHINA
Under the guidance of Academician Sun Yinghao, RALRP was provided to a 65 year old local patient, who was admitted to the hospital for early prostate cancer, the whole surgery lasted 1.5 hours. Post-surgery, the patient recovered with good ...
CONTACT SUPPLIER

IsoPSA - Prostate Biopsy Testing System

IsoPSA - Prostate Biopsy Testing System

Manufactured by:Cleveland Diagnostics, Inc.   based inCleveland, OHIO (USA)
IsoPSA Proceed to biopsy only when needed. IsoPSA is now included in NCCN® Prostate Cancer Early Detection Guidelines. IsoPSA can help reduce unnecessary prostate biopsies by up to 55%. Up to 75% of results from prostate biopsies performed in the US are negative for high-grade disease. By singling out PSA ...
CONTACT SUPPLIER

SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer

SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer

Manufactured by:MDxHealth   based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the ...
CONTACT SUPPLIER

ConfirmMDx - Actionable Molecular Diagnostic System for Prostate Cancer

ConfirmMDx - Actionable Molecular Diagnostic System for Prostate Cancer

Manufactured by:MDxHealth   based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise cancer-free men from undergoing unnecessary ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Industry Products
  • Medical Industry Software
  • Medical Industry Training
  • Medical Industry Services
  • Medical Industry Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles
  • Medical Industry Books
  • Medical Industry Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT